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ttp://dx.doi.org/10.1016/j.ajpath.2014.08.022b-catenin regulates the establishment of hepatic metabolic zonation. To elucidate the functional
signiﬁcance of liver metabolic zonation in the chronically overfed state in vivo, we fed a high-fat diet
(HFD) to hepatocyte-speciﬁc b-catenin transgenic (TG) and knockout (KO) mice. Chow-fed TG and KO
mice had normal liver histologic ﬁndings and body weight. However, HFD-fed TG mice developed
prominent perivenous steatosis with periportal sparing. In contrast, HFD-fed KO mice had increased
lobular inﬂammation and hepatocyte apoptosis. HFD-fed TG mice rapidly developed diet-induced
obesity and systemic insulin resistance, but KO mice were resistant to diet-induced obesity. Howev-
er, b-catenin did not directly affect hepatic insulin signaling, suggesting that the metabolic effects of
b-catenin occurred via a parallel pathway. Hepatic expression of key glycolytic and lipogenic genes was
higher in HFD-fed TG and lower in KO mice compared with wild-type mice. KO mice also exhibited
defective hepatic fatty acid oxidation and fasting ketogenesis. Hepatic levels of hypoxia inducible
factor-1a, an oxygen-sensitive transcriptional regulator of glycolysis and a known b-catenin binding
partner, were higher in HFD-fed TG and lower in KO mice. KO mice had attenuated perivenous hypoxia,
suggesting disruption of the normal sinusoidal oxygen gradient, a major determinant of liver carbo-
hydrate and liver metabolism. Canonical Wnt signaling in hepatocytes is essential for the development
of diet-induced fatty liver and obesity. (Am J Pathol 2014, 184: 3284e3298; http://dx.doi.org/
10.1016/j.ajpath.2014.08.022)Supported in part by NIH grant 5K08AA017622 (J.B.).
Disclosures: None declared.
Current address of L.A., Division of Diabetes, Department of Medicine,
University of Massachusetts Medical School, Worcester, MA; of V.P.S.,
Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.The liver exhibits remarkable metabolic plasticity that allows
it to play a central role in systemic energy homeostasis.
During periods of starvation, the liver is a major source of
energy via hepatic glucose and ketone body production. In
contrast, after feeding, the liver suppresses glucose produc-
tion, takes up glucose, up-regulates lipogenesis, and helps to
restore normoglycemia.1 Dysfunction of these normal
physiologic processes plays a role in the pathogenesis of
major metabolic disorders, such as obesity, diabetes mellitus,
and nonalcoholic fatty liver disease (NAFLD). Thus, it is
critical to elucidate the molecular pathways that regulate
normal liver metabolic function.
The mammalian liver exhibits metabolic zonation, which
is characterized by the heterogeneous distribution of meta-
bolic function across the hepatic lobule.2 Functions such as
oxidative phosphorylation and gluconeogenesis predominate
in the periportal (zone 1) region. In contrast, glycolysis,stigative Pathology.
.lipogenesis, and xenobiotic metabolism occur predominantly
in the perivenous (zone 3) region.2,3 Most metabolic func-
tions exhibit dynamic zonation, depending on the prevailing
nutritional state. In contrast, some functions (eg, expression
of glutamine synthetase [GS] in a narrow rim of perivenous
hepatocytes) exhibit ﬁxed zonation that does not vary with
the feeding cycle.
b-catenin, the central player in the canonicalWnt signaling
pathway, plays a critical role in establishing liver metabolic
zonation. Targeted deletion of b-catenin in hepatocytes
causes expansion of the periportal gene expression program
b-Catenin Links Hepatic Lipid Metabolismand down-regulation of many perivenous genes. Conversely,
constitutive activation of b-catenin expands the perivenous
gene expression program and down-regulates expression of
periportal genes.4 Currently, we do not understand the pre-
cise role of metabolic zonation in liver and systemic carbo-
hydrate and lipid metabolism in vivo. We used liver-speciﬁc
b-catenin knockout (KO) and transgenic (TG) mice to
determine the effect of manipulating liver metabolic zonation
in the chronically overfed state. We found that by linking
metabolic zonation with lipogenesis and systemic energy
balance, b-catenin, plays a critical role in conferring meta-
bolic plasticity to the liver.
Materials and Methods
Animals and Dietary Treatments
Liver-speciﬁc b-catenin KO mice (Ctnnb1loxp/loxp;Alb-Creþ/)
in a C57Bl/6 background were generated as previously
described.5 Littermates with wild-type Ctnnb1 allele were
used as controls. Liver-speciﬁc b-catenin TG mice were a
gift of Dr. Satdarshan Monga (University of Pittsburgh,
Pittsburgh, PA) and were generated as previously
described.6 TG mice express, under control of the
hepatocyte-speciﬁc albumin promoter, b-catenin protein
carrying a mutation (S45D) that makes it resistant to pro-
teasomal degradation. TG mice were generated in a mixed
background and backcrossed for six generations into the
C57BL/6 background.
Male mice between 8 and 12 weeks of age were used
for all experiments. The animals were maintained under a
12-hour dark/light cycle and had free access to food and
water. An adjusted calorie high-fat diet (HFD; Harlan
Teklad TD.88137, Harlan Laboratories, Indianapolis, IN;
4.5 kcal/g with 15.2% kcal from protein, 42.7% kcal from
carbohydrate, and 42% kcal from fat) or chow diet
(Teklad Global Diet 2018, Harlan Laboratories; 3.1 kcal/g
with 24% kcal from protein, 58% kcal from carbohydrate,
and 18% kcal from fat) was used for 1 to 8 weeks as
indicated in Results. For experiments with HFD and
chow-fed mice, animals were fasted for 4 hours before
sacriﬁce. For fasting-refeeding experiments, chow-fed
mice were fasted overnight (16 hours) and sacriﬁced at
7 AM or fasted overnight and then refed for exactly 6
hours and sacriﬁced at 1 PM. In all experiments and at each
time point, the KO or TG mice were paired with corre-
sponding wild-type (WT) animals to allow comparisons
among genotypes. All animal experiments were per-
formed with the approval of the University of Pittsburgh
Institutional Animal Care and Use Committee and in
accordance with NIH guidelines.
Serum and Liver Biochemical Assays
Blood glucose was measured using an Ascencia XL Gluc-
ometer or a commercially available kit from StanbioThe American Journal of Pathology - ajp.amjpathol.orgLaboratory (Boerne, TX; catalog no. 1070). Serum insulin was
measured by radioimmunoassay (Linco sensitive rat insulin
radioimmunoassay kit; Millipore, Billerica, MA). The serum
glutamine level was measured by quantitative colorimetric
determination via a commercially available assay kit
(BioAssay Systems, Hayward, CA; catalog no. EGLN-100).
Serum b-hydroxybutyrate levels were measured using an
automated analyzer by the University of Pittsburgh Medical
Center Clinical Chemistry Laboratory. Serum and liver tri-
glyceride and cholesterol assays were performed as previously
described.7,8
Glucose Tolerance Test, Insulin Treatment, and
Hyperinsulinemic-Euglycemic Clamp Studies
Glucose tolerance test was performed in mice fasted for 16
hours followed by 1-g/kg intraperitoneal glucose injection.
Blood glucose was measured from the tail vein at baseline
and 15, 30, 60, and 90 minutes using a glucose meter. For
treatment with insulin, mice maintained on chow diet were
fasted overnight and injected with an i.p. bolus injection of
insulin (2 U/kg). Mice were euthanized after 20 minutes and
livers rapidly harvested and snap frozen in liquid nitrogen for
further analysis.
For insulin clamp studies, catheters were chronically
implanted in the left femoral artery and vein for measure-
ment of blood glucose and for infusion of insulin and
radioisotope tracers. After a 48- to 72-hour recovery period
after catheter placement, serum was collected from
overnight-fasted mice for measurement of plasma insulin,
free fatty acids, and glucose. Baseline hepatic glucose
output was determined during a 120-minute period by
infusing [3-3H]glucose (10-mCi bolus þ 0.1 mCi/minute;
NEN Life Science Products, Boston, MA) through the
femoral vein using a microdialysis pump. A 100-mL sample
of arterial blood was collected at 120 minutes for determi-
nation of plasma glucose, insulin, and [3-3H]glucose levels.
After the basal period, a 2-hour hyperinsulinemic euglyce-
mic clamp procedure was performed. Whole-body insulin
sensitivity was determined by infusing a constant rate of
human insulin and a variable rate of dextrose 50% glucose
through the femoral venous catheter and maintaining
plasma glucose at 100 to 125 mg/dL. Blood glucose levels
were sampled from the femoral artery catheter at 10-minute
intervals using a glucose meter. The mean glucose infusion
rate during the last 30 minutes of the insulin clamp was used
to determine insulin sensitivity.
Histologic and IHC Evaluation of the Liver
Formalin-ﬁxed, parafﬁn-embedded liver sections were
stained with hematoxylin and eosin (H&E) or Oil Red O
as previously described.5 Liver sections were stained with
b-catenin (1:200), cytochrome P450 (Cyp) 2E1 (1:100),
and GS (1:100) antibodies from Abcam (Cambridge, MA)
using standard immunohistochemical (IHC) techniques.3285
Behari et alStaining for apoptotic cells by the terminal deoxy-
nucleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) method was performed using the ApopTag
Peroxidase Kit (Millipore; catalog no. S7100). LiverFigure 1 High-fat diet (HFD)efed transgenic (TG) mice have a predominantly p
8 weeks. For tissue collection, mice were fasted for 4 hours from 7 AM and sacriﬁce
wild-type (WT) mice. B: Liver/body weight ratio. C: Liver sections stained with
steatosis with periportal sparing in TG/HFD livers. D: Magniﬁed view of hepatocyt
levels. Data are expressed as means  SEM of ﬁve mice per group (chow) and sev
Original magniﬁcation: 100 (C, top row); 200 (C, remaining rows, and D). C
3286cryosections were stained for glucokinase (GCK; 1:50;
Santa Cruz Biotechnology, Santa Cruz, CA) and immu-
noﬂuorescence microscopy performed as previously
described.7erivenous pattern of liver steatosis. Mice were fed the HFD or chow diets for
d at 11 AM. A: Gross appearance of the liver from chow and HFD-fed TG and
hematoxylin-eosin and Oil Red O. Note the strongly perivenous pattern of
es from HFD-fed WT and TG liver. E: Liver triglyceride and total cholesterol
en mice per group (HFD). *P < 0.05, **P < 0.01. Scale barZ 100 mm (C).
, central vein; P, portal area.
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and Real-Time PCR
Crude liver extracts were prepared as previously
described.8 Immunoblotting was performed using theFigure 2 High-fat diet (HFD)efed knockout (KO) mice exhibit periportal steatosis,
diets for 4 weeks. Mice were fasted for 4 hours from 7 AM and sacriﬁced at 11 AM for
chow- or HFD-fed wild-type (WT) and KO mice. B: Low power view of H&E-stained live
morphologic ﬁndings in mice on chow and HFD diets and quantitation of liver/body rati
as means SEM of ﬁvemice per group. E: Terminal deoxynucleotidyl transferase-media
KO mice (black arrowheads). F: Western blot analysis for activated caspase 3 (longer e
dehydrogenase is the internal loading control (shorter exposure). Scale barZ 100 mm
Neg, negative control; Pos, positive control (spleen sections).
The American Journal of Pathology - ajp.amjpathol.orgfollowing primary antibodies: b-catenin (BD Biosciences
and Cell Signaling, San Jose, CA), glyceraldehyde-3-
phosphate dehydrogenase (Abcam), fatty acid synthase
(Santa Cruz Biotechnology), GCK (Santa Cruz Biotech-
nology), hypoxia inducible factor (HIF)-1a (Novuslobular inﬂammation, and hepatocyte apoptosis. Mice were fed the HFD or chow
tissue collection. A: Hematoxylin and eosin (H&E)estained liver sections from
r sections. Note the foci of inﬂammatory cells in HFD-fed KO liver. C: Gross liver
o. D: Liver triglyceride and total cholesterol levels at 4 weeks. Data are presented
ted dUTP nick-end labeling staining reveals apoptotic cells in livers fromHFD-fed
xposure emphasizes differences in C3 expression). Glyceraldehyde-3-phosphate
(A and B). Original magniﬁcation:200 (A);100 (B);400 (E). *P< 0.05.
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Behari et alBiologicals, Littleton, CO), phosphor-Akt (Ser473),
phosphor-Akt (Thr308), pan-Akt, phosho-S6, S6, phos-
phor-GSK-3b (Ser9), and GSK-3b (all from Cell
Signaling), peroxisome proliferator-activated receptor
(PPAR)-g (Santa Cruz), a-tubulin (Abcam), cytochrome c
oxidase (COX) IV antibody (Cell Signaling), andFigure 3 Zonal expression patterns of b-catenin and its target genes on mice f
For tissue collection, mice were fasted for 4 hours from 7 AM and sacriﬁced at 11
and transgenic (TG) mice stained with b-catenin, Cyp2E1, or GS as indicated. He
marked with white arrowheads. Note the absence of Cyp2E1 and GS staining in K
and TG mice. Also note the correlation between Cyp2E1 staining and hepatocyte
3288peroxisome proliferator-activated receptor gamma coac-
tivator (PGC)-1a (Novus Biologicals). Western blots were
quantiﬁed using densitometric analysis using the ImageJ
version 1.44 (NIH, Bethesda, MD).9 Results from two
experiments, each with two samples per group, were
averaged and normalized to the corresponding loadinged the high-fat diet (HFD). Mice were fed the HFD or chow diets for 4 weeks.
AM. A: Liver sections from chow- or HFD-fed knockout (KO), wild-type (WT),
patocytes with cytoplasmic and nuclear b-catenin staining on the HFD are
O mice and the perivenous zonal pattern of expression of both genes in WT
steatosis in HFD-fed TG mice.
ajp.amjpathol.org - The American Journal of Pathology
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Taqman primers (Applied Biosystems, Carlsbad, CA) as
previously described.8
Metabolic Cage Experiment
The respiratory exchange ratio, activity, and stool output were
measured in an Oxymax Comprehensive Laboratory AnimalFigure 4 Hepatic b-catenin regulates systemic energy homeostasis. A: Body w
and high-fat diet (HFD)efed transgenic (TG) and wild-type (WT) mice. Mice were f
collection at 11 AM. B: Body weight change, morphologic ﬁndings, and perigonada
chow or HFD for 4 weeks and fasted for 4 hours before sacriﬁce for tissue collection
HFD expressed as the total of X (horizontal) and Z (vertical) movements measur
measured during the metabolic cage experiment. F: Feces dry weight on the HFD d
prepared from various organs from WT and KO mice. Glyceraldehyde-3-phosphate d
5 to 7 per group (B); n Z 5 per group (CeF). *P < 0.05 (AeD and F). Pancr, p
The American Journal of Pathology - ajp.amjpathol.orgMonitoring System (Columbus Instruments, Columbus, OH)
with 1 mouse per chamber. WT and KOmice were allowed ad
libitum access to the HFD for 1 week before the experiment.
On day 7, mice were weighed and placed in the chamber at 10
AM and allowed to acclimate for 4 hours. Measurements for
oxygen consumption, carbon dioxide consumption, and ac-
tivity were recorded on a computer every 10 minutes for the
next 20 hours at room temperature. The animals had freeeight change, morphologic ﬁndings, and perigonadal fat pads from chow-
ed chow or HFD for 8 weeks and fasted for 4 hours before sacriﬁce for tissue
l fat pads from chow and HFD-fed WT and knockout (KO) mice. Mice were fed
at 11 AM. C: Respiratory exchange ratio on the HFD. D: Activity level on the
ed in the metabolic cage. E: Food intake in HFD-fed WT, TG, and KO mice
uring 24 hours. G: Protein immunoblot analysis for b-catenin using lysates
ehydrogenase was used as a loading control. nZ 5 to 8 per group (A); nZ
ancreas; VAT, visceral adipose tissue; Vastus, vastus muscle.
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Figure 5 b-catenin indirectly regulates hepatic insulin signaling. A:
Fasting or random serum glucose from high-fat diet (HFD)efed wild-type (WT)
and transgenic (TG) mice and serum insulin levels from chow or HFD-fed WT
and TG mice collected after 4 hours of fasting. B: I.P. glucose tolerance tests
(GTTs) in chow and HFD-fed WT and TG mice. C: Hyperinsulinemic-euglycemic
clamp studies with chow-fed WT and TG mice revealing glucose infusion rate,
blood glucose levels during the clamp, and hepatic glucose production. D:
Hepatic glucose output measured during the insulin clamp study. E: Western
blot analysis for proteins in the insulin-signaling pathway. Chow-fed, 16-hour
overnight fasted mice were injected i.p. with saline (minus sign) or insulin
(plus sign) and livers were harvested after 20 minutes. nZ 4 to 5 per group
(A), nZ 5 per group (BeD). *P < 0.05, ***P < 0.001.
Behari et alaccess to food and water during the experiment. The respira-
tory exchange ratio was measured as carbon dioxide con-
sumption/oxygen consumption, and activity was calculated as
the sum of x þ z (ambulatory and vertical movements,
respectively) scores. Food intake and stool output were
measured at the end of the experiment.
ChIP Assay
Chromatin immunoprecipitation (ChIP) assayswere performed
using the Millipore ChIP assay kit (catalog no. 17-295) as
previously described.7 The human hepatoma cell line Hep3B
and transcription factor (TCF)-4 antibody (Millipore; catalog
no. 17-10109) were used for the ChIP assay. Positive control
primers for the SP5 promoter were as follows: 50-GGGTC-
TCCAGGCGGCAAG-30 (forward primer) and 50-AGCGA-
AAGCAAATCCTTTGAATCC-30 (reverse primer). Scanning
ChIP primers were designed at 300- to 400-bp intervals along
the liver-speciﬁc human Gck promoter. The primers spanned a
region from 3000 to þ200 bp relative to the liver-speciﬁc
transcription start of the Gck promoter. An unrelated promoter
(b-actin) was used as the negative control. Scanning primer
sequences are available on request.
Hypoxia Studies and Pimonidazole Staining for Tissue
Hypoxia
Mice were placed in regular cages customized to deliver
varying concentrations of inspired oxygen. A gas control de-
livery system regulated the ﬂow of oxygen, nitrogen, and room
air into the customized cages, and a series of ﬂow regulators
allowed the manipulation of inspired oxygen.10 In the inter-
mittent hypoxia group, oxygen levels decreased from 21% to
6% for a 30-second period followed by quick reoxygenation to
room air levels via a burst of 100% oxygen (60 cycles hour1).
A second set ofmicewas exposed to continuous hypoxia in the
customized cages during which the oxygen concentration was
maintained at 10%. Control animals (sham treated) were
housed in the same customized cages at the same time as the
treated animals but only exposed to room air (21% oxygen).
The Hypoxyprobe-1 Omni kit (HPI Inc., Burlington, MA) was
used for the detection of tissue hypoxia. Pimonidazole hy-
drochloride was administered by i.p. injection at a dosage of 60
mg/kg. Liver tissue was collected after 60 minutes. Pimoni-
dazole is reductively activated in hypoxic cells, and the acti-
vated intermediate forms stable covalent adducts with
proteins.11 IHC for protein adducts of pimonidazole was per-
formed with PAb2627AP, an afﬁnity puriﬁed rabbit antibody
as per the manufacturer’s recommendations (HPI Inc.).
Determination of Mitochondrial Biogenesis
Mitochondrial DNA copy number was determined using a
modiﬁcation of a previously described approach.12 Total DNA
was prepared from liver tissue usingDNeasy spin columns and
DNA concentration measured spectrophotometrically. The3290quantity of mitochondrial-encoded COX1 relative to the
nuclear-encoded gene 18S rRNA was measured using Taq-
Man real-time using proprietary primers (Applied Biosystems;
Mm04225243_g1). Mitochondrial aerobic capacity was
measured by assaying for the activity of the mitochondrial
matrix enzyme citrate synthase activity as previously
described.7
Palmitate Oxidation Assays
Fatty acid oxidation was determined ex vivo in freshly
harvested livers as previously described.13 Liver sections
were weighed (approximately 200 mg per well) and incu-
bated in Dulbecco’s modiﬁed Eagle’s medium/10% fetal
bovine serum in the presence of 0.1 mmol/L palmitate and
[3H]-palmitate (20 mCi per well) at 37C for 2 hours in
duplicate wells for each animal. Tritiated water wasajp.amjpathol.org - The American Journal of Pathology
b-Catenin Links Hepatic Lipid Metabolismdetermined in the collected medium by a vapor-phase
equilibration method.
Statistical Analysis
Results were analyzed by Student’s t-test for comparison
between the two groups and by one-way analysis of vari-
ance when more than two groups were compared. P < 0.05
was considered signiﬁcant.
Results
Hepatic b-Catenin Determines Zonal Patterns of Liver
Steatosis on the HFD
On chow diet, TG mice exhibited grossly normal liver but
8% higher liver/body ratio compared with WT mice, as
previously described (Figure 1, A and B).6 TG mice alsoFigure 6 b-catenin regulates hepatic fatty acid oxidation, ketogenesis, and
overnight fasted, chow-fed mice. B: Serum b-hydroxybutyrate (BHB) levels from fa
activity in isolated mitochondria from freshly harvested livers of chow-fed wild-t
(mtDNA) content of chow- (white bars) and high-fat diet (HFD)efed mice at 4 we
the ratio of the mitochondrial gene COXI and the nuclear gene 18S rRNA measured
and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1a in l
loading control. Mice were fed the chow or HFD diets for 4 weeks and fasted for
Western blot results from E. Results are expressed as means  SEM of four samp
relative value compared with the WT/chow group. n Z 5 per group (A and B), n
The American Journal of Pathology - ajp.amjpathol.orghad normal serum biochemical assay results (data not
shown). On histologic examination, neither group of mice
exhibited liver steatosis on chow diet. However, at 8 weeks
on the HFD, TG mice exhibited grossly larger and steatotic
livers but similar liver/body ratio to WT mice (Figure 1, A
and B). On H&E staining, HFD-fed TG mice had a striking
increase in hepatic steatosis in perivenous and midzonal
hepatocytes. In contrast to the lipid-laden perivenous he-
patocytes, we observed almost no steatosis in periportal
hepatocytes in HFD-fed TG mice (Figure 1C). Oil Red O
staining revealed a higher amount of neutral lipid in he-
patocytes from HFD-fed TG mice (Figure 1C). Hepato-
cytes in HFD-fed TG mice were larger than in HFD-fed
WT mice and engorged with microvesicular and macro-
vesicular steatosis (Figure 1D). HFD-fed TG mice had
threefold higher liver triglyceride levels but similar total
cholesterol levels compared with WT mice (Figure 1E).
We treated another set of WT and TG mice with chow andmitochondrial function. A: Palmitate oxidation rate in liver sections from
sted (white bars) and refed (black bars) chow-fed mice. C: Citrate synthase
ype (WT) and knockout (KO) mice. D: Relative hepatic mitochondrial DNA
eks (gray bars) and 8 weeks (black bars). mtDNA content was determined as
by real-time PCR. E: Western blot analysis for cytochrome c oxidase (COX) IV
ivers of WT, KO, and transgenic (TG) mice on chow or HFD. Tubulin is the
4 hours before sacriﬁce for tissue collection at 11 AM. F: Quantiﬁcation of
les per group normalized to the internal loading control and expressed as
Z 4 to 5 per group (D). *P < 0.05.
3291
Behari et alHFD for 4 weeks. TG mice fed the HFD for 4 weeks had a
phenotype similar to that at 8 weeks, except that weight
gain (data not shown) and degree of perivenous steatosis
(Supplemental Figure S1) were less striking at 4 weeks
than at 8 weeks.
KO mice had similar histologic appearance to WT mice
on chow diet. However, at 4 weeks, HFD-fed KO mice hadFigure 7 b-catenin regulates expression of glycolytic and lipogenic genes in
synthase (FAS), glucokinase (GCK), and peroxisome proliferator-activated receptor
4 weeks) or WT and transgenic (TG) mice (at 8 weeks). B: Real-time PCR assays
glycolysis (Gck and Pklr), lipogenesis (Fasn and Scd1), lipid droplet (Plin2), gluc
(Acadm and Acox1), and regulators (Hnf4a and Srebf1). Results are from chow-
Immunoblot for hepatic GCK from chow-fed fasted and refed mice. a-Tubulin was
analysis in Hep3B cells for binding of transcription factor (TCF)-4 to the 2-kb li
controls. For fasting-refeeding experiments, mice were fasted overnight for 16 ho
AM, and refed mice were sacriﬁced for tissue collection at 1 PM. n Z 5 per grou
3292more prominent periportal steatosis with relative perivenous
sparing (Figure 2A). HFD-fed KO mice also exhibited
increased lobular inﬂammation (Figure 2B). However, WT
and KO mice exhibited similar gross appearance of the liver
on the HFD (Figure 2C). HFD-fed KO mice had lower
hepatic triglyceride levels but similar total cholesterol levels
compared with WT mice (Figure 2D).mice on the high-fat diet (HFD). A: Immunoblots for hepatic fatty acid
(PPAR)-g from chow or HFD-fed wild-type (WT) and knockout (KO) mice (at
for steady-state mRNA levels of important metabolic genes as indicated:
oneogenesis (Pck1 and G6pc), ketogenesis (Hmgcs2), fatty acid oxidation
fed overnight fasted (white bars) and 6-hour refed (black bars) mice. C:
the internal loading control in A and C. D: Chromatin immunoprecipitation
ver-speciﬁc Gck promoter. SP5 is shown as positive and actin as negative
urs and refed for 6 hours starting at 7 AM. Fasted mice were sacriﬁced at 7
p (B). *P < 0.05.
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livers from HFD-fed KO mice (Figure 2E and Supplemental
Figure S2), and Western blot analysis revealed higher acti-
vated caspase 3 levels in livers of HFD-fed KO mice
(Figure 2F and Supplemental Figure S3). Thus, KO mice
exhibited lower hepatic triglyceride accumulation but higher
HFD-induced hepatocyte toxic effects. In HFD-fed TG
mice, we found no difference in TUNEL staining or acti-
vated caspase 3 level in the liver relative to HFD-fed WT
mice (data not shown).
Effect of HFD on b-Catenin and Zonal Expression
Patterns of Its Target Genes
As expected, hepatocytes were negative for b-catenin staining
in KO mice. However, HFD-fed TG mice frequently had
cytoplasmic and nuclear staining for b-catenin in hepatocytes
(Figure 3 and Supplemental Figure S4).
Two well-established b-catenin target genes, Cyp2E1 and
GS, exhibit differential perivenous expression patterns.
Cyp2E1 exhibits dynamic zonation, whereas GS exhibits
ﬁxed zonation in a narrow rim of perivenous hepatocytes. We
found increased intensity of Cyp2E1 staining and expansion
of the perivenous zone of expression in HFD-fed WT mice
(Figure 3). We observed no hepatic Cyp2E1 staining in KO
mice. In chow-fed TG mice, we found that a wider zone of
perivenous hepatocytes stained positive for Cyp2E1. In HFD-
fed TG mice, Cyp2E1 expression expanded to the midzonal
region and strongly correlated with steatosis within hepato-
cytes (Figure 3).
In contrast to Cyp2E1, we found no difference between
chow- andHFD-fedWTmice in the zonal pattern of expression
of GS. KO mice did not express GS in the liver. TG mice
exhibited more intense GS staining but in a zonal expression
pattern that was similar to that in WT mice (Figure 3).
Consistent with the changes in hepaticGS expression, KOmice
exhibited lower and TGmice higher serum glutamine levels on
chow and HFD diets compared with WT mice (Supplemental
Figure S5).
Hepatic b-Catenin Modulates Development of
Diet-Induced Obesity
On chow diet, WT and TG mice had similar weight and were
morphologically indistinguishable. However, HFD-fed TG
mice gained more weight and at 8 weeks exhibited prominent
visceral fat and higher perigonadal fat pad mass compared
withWTmice (Figure 4A). On chow diet, KOmice had body
weight and visceral fat similar to WT mice. However, HFD-
fed KOmice gained less weight and exhibited less prominent
visceral fat and lower perigonadal fat pad mass at 4 weeks
compared with WT mice (Figure 4B and Supplemental
Figure S6).
We next performed metabolic cage experiments with
mice fed the HFD for 1 week to acclimatize them to the diet
but avoid potential compensatory changes. Compared withThe American Journal of Pathology - ajp.amjpathol.orgWT mice, HFD-fed KO mice exhibited overall higher and
TG mice lower respiratory exchange ratio (3%, P < 0.01)
(Figure 4C). The three genotypes had similar activity levels
and normal circadian variation in activity (Figure 4D).
Food intake was similar between the mice (Figure 4E).
HFD-fed KO mice but not TG mice had twofold higher
stool mass, suggesting defects in intestinal fat absorption
(Figure 4F). To ensure that these systemic effects resulted
from hepatic b-catenin disruption, we conﬁrmed that b-
catenin expression was intact in extrahepatic tissues
(Figure 4G).
b-Catenin Does Not Directly Affect Hepatic Insulin
Signaling
Random and fasting serum glucose levels were similar in
HFD-fed WT and TG mice. In contrast, HFD-fed TG mice
exhibited higher fasting serum insulin levels (Figure 5A).
TG mice also exhibited impaired glucose tolerance on the
HFD but not chow diet (Figure 5B). Similar to previously
published results, KO mice exhibited improved insulin
sensitivity on both chow and HFD (data not shown).14
We next performed hyperinsulinemic-euglycemic clamp
studies on long-term catheterized conscious mice to deter-
mine the mechanism of HFD-induced insulin resistance.
Chow-fed TG and WT mice had similar insulin sensitivity
and hepatic glucose production (Figure 5, C and D). These
results suggest that insulin resistance in HFD-fed TG mice
was the result of increased adiposity and fatty liver and not
the mutant b-catenin allele per se.
To determine the effect of b-catenin on insulin signaling, we
treated chow-fed, overnight fasted WT, KO, and TG mice with
insulin. In the fasting state or after insulin treatment, we found
similar phosphorylation patterns of proteins (Akt, GSK-3b, and
S6) in the insulin-signaling pathway (Figure 5E). We conclude
that b-catenin does not directly affect hepatic insulin signaling.
b-Catenin Regulates Hepatic Fatty Acid Oxidation,
Ketogenesis, and Mitochondrial Function
In the fasting state, both mitochondrial fatty acid oxidation
and ketogenesis predominate in periportal hepatocytes.15
We hypothesized that an underlying mitochondrial defect
contributes to periportal steatosis in HFD-fed KO mice.
We found that chow-fed KO mice had lower hepatic
palmitate oxidation rate ex vivo (Figure 6A). Chow-fed
fasted KO mice also exhibited lower serum levels of the
ketone body b-hydroxybutyrate, suggesting defective
fasting ketogenesis (Figure 6B). We also found lower
mitochondrial activity of citrate synthase, the rate-limiting
step in the tricarboxylic acid cycle, in fasted chow-fed KO
mice (Figure 6C). Thus, KO mice have defective mito-
chondrial function in the liver.
Wnt signaling regulates mitochondrial biogenesis.16 There-
fore, we asked whether changes in b-catenin affected hepatic
mitochondrial biogenesis. Mitochondrial DNA content, as3293
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encoded COXI and nuclear-encoded 18S rRNA, was lower
in HFD-fed KO and higher in TGmice at 4 weeks (Figure 6D).
Immunoblot for COXIV protein revealed higher levels of the
protein in chow and HFD-TG mice compared with WT ani-
mals, although levels between KO and WT mice were similar
(Figure 6E). We found a higher level of PGC-1a protein, an
important regulator of mitochondrial biogenesis, in KO mice
and a similar level in TG mice compared with WT mice
(Figure 6F). Thus, b-catenin affects mitochondrial biogenesis
via a PGC-1aeindependent pathway.b-Catenin Regulates Expression of Glycolytic and
Lipogenic Genes on the HFD
In HFD-fed KO mice, we found lower protein levels of
hepatic fatty acid synthase, a key lipogenic enzyme, and
GCK, an important hepatic glycolytic enzyme. In contrast,
we found higher levels of both proteins in HFD-fed TG
mice (Figure 7A). However, levels of the lipogenesis
regulator PPAR-g were similar between the genotypes.
Thus, b-catenin regulates HFD-induced hepatic glycolysis
and lipogenesis independently of PPAR-g.
We next determined by real-time PCR whether b-catenin
regulates expression of important metabolic genes in the
liver. To avoid the confounding effects of HFD-induced
changes in adiposity and insulin signaling, we performed
these assays using livers from chow-fed mice that were fasted
overnight or fasted and then refed for 6 hours. Expression of
most tested genes was similar between the mice (Figure 7B).
However, KO mice failed to up-regulate Gck and Fasn
(encoding fatty acid synthase) in the fed state, whereas TG
mice had higher GCK expression in the fasting state. Unlike a
previously published report, we found no difference in glu-
coneogenic gene expression between theWT and KOmice.14
GCK is a critical regulator of glycolysis and lipogenesis in
the liver.17 Therefore, we focused on Gck. We found that the
GCK protein was lower in chow-fed fasted and refed KO
mice and higher in fed TG mice (Figure 7C). However, un-
like our PCR results, we did not ﬁnd higher GCK levels inFigure 8 b-catenin regulates zonal oxygen gradients and affects hypoxia-indu
chow- and high-fat diet (HFD)efed mice and its quantiﬁcation. a-Tubulin was th
samples per group normalized to the internal loading control and expressed as r
(brown) for tissue hypoxia in livers of chow-fed wild-type (WT) and knockout (KO)
cycles hour1 of 21% oxygen alternating with 6% oxygen for 30 seconds each
pimonidazole injection was performed at 11 AM followed by sacriﬁce for tissue
b-catenin and hepatocyte bioenergetics, metabolic zonation, and lipid homeosta
genesis, predominate in the oxygen-rich periportal zone, whereas glycolysis and
expands the periportal functions, and feeding expands the perivenous function
mitochondrial and microsomal function in both periportal and perivenous hepa
glycolysis and linked lipogenesis in the hypoxic perivenous zone. b-catenin disr
gluconeogenesis, and fatty acid oxidation) and perivenous microsomal functions
gradient, and down-regulation of HIF-1aemediated glycolysis and lipogenesis in t
of sinusoidal blood ﬂow (eg, via Hmox1), may also play a role.5,37 Decreased hepat
insulin sensitivity in KO mice but increases susceptibility of the liver to lipotoxic
hepatic glycolysis and lipogenesis, leading to diet-induced obesity and systemic
The American Journal of Pathology - ajp.amjpathol.orgfasted TG mice, a discrepancy that may be due to post-
transcriptional regulation of Gck.
We performed ChIP assay in the human hepatoma cell
line Hep3B to determine whether Gck is a direct b-catenin
target. We did not detect binding by b-catenin or its tran-
scriptional coactivator TCF7L2 (also called TCF4), along
the 2-kb liver-speciﬁc Gck promoter region (Figure 7D).b-Catenin Disruption Affects the Zonal Oxygen
Gradient and Levels of HIF-1a
HIF-1a is an oxygen-sensitive transcriptional activator ofGck
and glycolysis. Under hypoxic conditions, HIF-1a signaling in
the liver depends on b-catenin.18 We found that hepatic HIF-
1a protein levels were lower in HFD-fed KO and higher in TG
mice compared with WT mice (Figure 8A).
HIF-1a is subject to hypoxic regulation and rapidly de-
grades in nonhypoxic conditions. To determine whether loss
of b-catenin affected the lobular oxygen gradient, we injected
chow-fedKO andWTmice that were breathing room air (21%
oxygen) with pimonidazole, a marker of tissue hypoxia. WT
mice had perivenous staining for pimonidazole adducts. In
contrast, KO animals had attenuated perivenous pimonidazole
staining (Figure 8B). To determine whether the zonal pattern
of pimonidazole staining was truly due to perivenous hypoxia
or perivenous expression of enzymes affecting pimonidazole
binding (eg, nitrosoreductases), we manipulated the inspired
oxygen concentration to determine its affect on pattern of
pimonidazole staining. WT and KO mice were exposed to
intermittent hypoxia (30-second alternating cycles of 21%
oxygen and 6% oxygen), continuous hypoxia (steady expo-
sure to 10% oxygen) (Figure 8B), or room air (21% oxygen as
control). Intermittent hypoxia-exposed WT mice had
increased intensity and distribution of pimonidazole staining
in a perivenous distribution compared with room aire
breathing WT mice. On exposure to continuous hypoxia, WT
mice had a bridging hypoxia pattern of pimonidazole staining,
strongly supporting a model of lower sinusoidal oxygen con-
centration in the perivenous zone relative to the periportal
zone. Under the two hypoxic conditions, KOmice had a subtlecible factor (HIF)-1a protein levels. A: Immunoblot for hepatic HIF-1a from
e internal loading control. Results are expressed as means  SEM of four
elative value compared with the WT/chow group. B: Pimonidazole staining
mice exposed to room air (Air; 21% oxygen), intermittent hypoxia (IH; 60
), and continuous hypoxia (CH; 10% oxygen). Mice were not fasted, and
collection 1 hour later. C: Hypothetical model reveals the link between
sis. Metabolic functions, such as oxidative phosphorylation and gluconeo-
lipogenesis predominate in the relatively hypoxic perivenous zone. Fasting
s, conferring metabolic plasticity to the normal liver. b-catenin regulates
tocytes, helps to establish the sinusoidal oxygen gradient, and promotes
uption in KO mice causes defects in mitochondrial functions (ketogenesis,
(eg, Cyp2E1) with decreased oxygen use, blunting of the sinusoidal oxygen
he perivenous zone. Additional factors, such as direct or indirect regulation
ic lipogenesis contributes to resistance to diet-induced obesity and systemic
effects. Transgenic (TG) mice have the opposite phenotype with increased
insulin resistance. n Z 4 mice per group (B). *P < 0.05.
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breathing KO mice, but the intensity and distribution of
pimonidazole stainingwere signiﬁcantly less than inWTmice.
We conclude that b-catenin is necessary for establishing the
normal sinusoidal oxygen gradient and likely regulates GCK
expression via HIF-1a.Discussion
Our study provides several novel insights into the role of ca-
nonical Wnt signaling and metabolic zonation in liver and
development of diet-induced obesity: i) b-catenin is necessary
but not sufﬁcient for the development of diet-induced fatty
liver; ii) b-catenin regulates the zonal distribution of liver
steatosis on the HFD; iii) b-cateninedependent changes in
hepatic metabolic zonation profoundly affect systemic
adiposity in the chronically overfed state; iv) b-catenin affects
mitochondrial function and hepatic fatty acid oxidation and
ketogenesis; and v) b-catenin regulates the sinusoidal oxygen
gradient, one of the major determinants of liver metabolic
function. Together, these complex effects of b-catenin link
metabolic zonation to the development of diet-induced fatty
liver, obesity, and systemic insulin resistance.
Our study contributes to the understanding of the func-
tional signiﬁcance of metabolic zonation of the mammalian
liver.2,3 Our results indicate that disruption of metabolic
zonation is dispensable in the unstressed liver. However,
metabolic zonation is critical for the liver to respond to
metabolic stress that results from starvation or chronic excess
of energy intake. Thus, dynamic metabolic zonation is the
key feature that confers the liver with its remarkable meta-
bolic plasticity and allows the liver to closely integrate its
metabolic responses with changes taking place in the rest of
the body. KO mice experience the deleterious effects of
chronic excess of energy intake in the absence of this hepatic
metabolic plasticity. KO mice have defective fasting-related
functions (gluconeogenesis, ketogenesis, and fatty acid
oxidation) and feeding-related functions (glycolysis and lipo-
genesis and weight gain on the HFD). Although KO mice
exhibit resistance to diet-induced obesity, this occurs at the
expense of increased hepatocyte apoptosis and inﬂammation.
In contrast, TG mice have the opposite phenotype with an
exaggerated response to HFD, characterized by striking liver
steatosis, diet-induced obesity, and rapid development of
systemic insulin resistance, likely related to the increased he-
patic lipogenesis on the HFD. Thus, tight regulation of hepatic
metabolic zonation appears to be a critical feature necessary
for optimum metabolic adaptation to long-term overfeeding.
Our results suggest that b-catenin exerts its complex
metabolic effects in part via modulating the sinusoidal oxy-
gen gradient. Mitochondria are the major consumers of ox-
ygen in cells, and periportal oxidative phosphorylation has
been proposed as one of the determinants of the sinusoidal
oxygen gradient.19e21 Our results suggest that mitochondrial
defects in KO livers not only affect periportal-predominant3296functions but also inﬂuence downstream perivenous-
predominant functions, such as glycolysis and lipogenesis.
Oxygen is a major regulator of hepatic metabolic zonation
and carbohydrate metabolism.21 HIF-1a is the critical
oxygen-sensing protein that regulates Gck and glycolytic
genes.22,23 Liver-speciﬁc HIF-1a KO mice are protected
from hepatic steatosis.24 We propose that amelioration of the
perivenous hypoxia in KOmice down-regulates hepatic HIF-
1a and Gck expression (Figure 8C). Our ﬁndings support
recent studies reporting that hypoxia promotes development
of fatty liver via increased lipogenesis.25,26 Our results sug-
gest that b-catenin indirectly regulates Gck expression.
However, b-catenin has complex regulatory functions that
are not fully understood. Therefore, we cannot exclude the
possibility that b-catenin regulates Gck by binding to sites
distal to its liver-speciﬁc promoter examined in our study.
Canonical Wnt signaling regulates mitochondrial biogen-
esis in a myoblast cell line.16 Our results support a similar
role of b-catenin in hepatocytes. Our ﬁndings add to
increasing evidence that supports a role for b-catenin in
regulating hepatic mitochondrial oxidative phosphoryla-
tion.7,27,28 We did not ﬁnd differences in gluconeogenic gene
expression between WT and KO mice.14 Because KO mice
exhibit mitochondrial dysfunction, we propose that these
defects underlie the observed abnormalities in gluconeo-
genesis and ketogenesis in KO mice. In addition, the asso-
ciated defects in fatty acid oxidation likely explain the severe
steatosis observed in KO mice on the methionine chol-
ineedeﬁcient diet, which promotes mobilization of fatty
acids to the liver but not increased lipogenesis.5
A surprising result of our study was that hepatocyte b-cat-
enin regulates development of diet-induced obesity. There are
several possible mechanisms for these effects: i) changes in
hepatic lipogenesis after a meal may affect the delivery of very
low-density lipoproteins from the liver to the rest of the body;
ii) b-catenin regulates bile acid homeostasis, which may
contribute to defective fat absorption and higher feces output
on the HFD in KO mice8; iii) HFD-induced liver steatosis
likely contributes to hepatic insulin resistance and affects en-
ergy balance throughout the body; iv) alterations in hepatic
mitochondrial ketogenesis and gluconeogenesis during fasting
inﬂuence metabolism in extrahepatic tissues; and v) KO mice
have lower and TG mice have higher serum glutamine levels
on chow and HFD diets. Glutamine plays a critical role in
regulation of anabolic pathways, such as mTOR, and also
regulates adipocyte function.29,30 Furthermore, b-catenin
plays a critical role in hepatic ammonia detoxiﬁcation, and KO
mice exhibit increased serum ammonia levels on a high-
protein diet. Thus, altered serum glutamine levels and
changes in ammonia detoxiﬁcation may be important links
between b-cateninedependent hepatic metabolic function and
systemic energy homeostasis. Further studies will be required
to clarify the relative contributions of these dynamic and
complex mechanisms on systemic metabolism.
Understanding the zonal patterns of liver steatosis carries
implications for elucidating the pathogenesis of NAFLD. Theajp.amjpathol.org - The American Journal of Pathology
b-Catenin Links Hepatic Lipid Metabolismmost common pattern of steatosis in NAFLD is perivenous.31
In contrast, predominantly periportal steatosis occurs in<1%
of patients. On the basis of our results, we propose that
conditions that promote increased hepatic lipogenesis favor
initial development of perivenous steatosis. Subsequent
development of mitochondrial dysfunction and fatty acid
oxidation defects provides additional pathways of lipid
accumulation, which expands the zone of steatosis to a
panlobular pattern. It is noteworthy that pediatric patients
with NAFLD have different liver histologic ﬁndings.32
Whether these dissimilarities between adults and children
represent differential zonal gene expression programs or di-
etary inﬂuences will require further investigations.33
Our study also has implications for understanding the
pathogenesis of metabolic disorders, such as diabetes and
obesity. Genome-wide association studies have linked
TCF7L2, a transcriptional co-activator of b-catenin, with
obesity and diabetes mellitus.34,35 Our results provide mech-
anistic insights into these genetic studies. Interestingly, in
adipose tissue inhibition, canonical Wnt signaling is necessary
for lipogenesis to proceed.36 Our results suggest that targeting
the canonical Wnt pathway as a therapeutic strategy in obesity
may carry risks because metabolic effects of b-catenin are
tissue speciﬁc.
In conclusion, our results indicate that b-catenin pro-
foundly affects multiple aspects of hepatic lipid metabolism,
including fatty acid oxidation, ketogenesis, and lipogenesis.
Overall, our results suggest that b-catenin plays a critical role
in both periportal and perivenous hepatic metabolic func-
tions. Besides being a master regulator of the perivenous
gene expression pattern, b-catenin is a key determinant of
hepatic metabolic plasticity that allows the liver to adapt to
both fasted and fed (or overfed) conditions. Thus, b-catenin
links hepatic metabolic zonation to liver lipid metabolism
and systemic energy homeostasis. Our results have important
implications for understanding the pathogenesis of fatty liver
disease, diet-induced obesity, and insulin resistance.
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